Boule Diagnostics AB (publ) (STO:BOUL)
3.650
+0.140 (3.99%)
Jul 24, 2026, 5:29 PM CET
Boule Diagnostics AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.6 | 19.63 | 22.65 | 37.28 | 96.9 | 38.18 |
Cash & Short-Term Investments | 19.6 | 19.63 | 22.65 | 37.28 | 96.9 | 38.18 |
Cash Growth | -14.78% | -13.35% | -39.24% | -61.53% | 153.79% | 15.75% |
Accounts Receivable | 118.7 | 128.8 | 146.16 | 153.87 | 143.57 | 127.89 |
Other Receivables | 9.1 | 5.2 | 11.32 | 14.47 | 12.06 | 11.76 |
Total Trade Receivables | 127.8 | 133.99 | 157.49 | 168.33 | 155.63 | 139.65 |
Inventory | 65.8 | 58.89 | 59.1 | 62.41 | 75.27 | 59.04 |
Other Current Assets | 18.8 | 12.84 | 15.54 | 11.91 | 10.61 | 5.51 |
Total Current Assets | 231.9 | 225.34 | 254.78 | 279.93 | 338.41 | 242.38 |
Net Property, Plant & Equipment | 62.9 | 58.01 | 39.48 | 44.27 | 58.57 | 47.43 |
Other Intangible Assets | 5.4 | 5.14 | 7.49 | 293.6 | 225.24 | 162.89 |
Goodwill | 83.4 | 79.76 | 91.92 | 85.45 | 88.12 | 78.69 |
Other Long-Term Assets | 97.1 | 101.32 | 123.24 | 51.86 | 49.62 | 40.65 |
Total Assets | 480.8 | 469.56 | 516.91 | 755.11 | 759.96 | 572.03 |
Accounts Payable | 32.5 | 26.03 | 31.68 | 35.71 | 33.32 | 41.17 |
Accrued Expenses | 32.8 | 33.18 | 53.71 | 40.53 | 37.08 | 36.36 |
Current Portion of Long-Term Debt | 138.4 | 129.76 | 129.35 | 84.52 | 91.7 | 92.05 |
Current Portion of Leases | 4.2 | 3.94 | 13.19 | 12.96 | 13.37 | 12.7 |
Other Current Liabilities | 8.7 | 14.12 | 34.57 | 29.28 | 25.56 | 28.93 |
Total Current Liabilities | 216.6 | 207.03 | 262.51 | 203 | 201.03 | 211.2 |
Long-Term Debt | 49.3 | 58.77 | 51.43 | 57.74 | 62.07 | 35.76 |
Long-Term Leases | 35.4 | 31.3 | 1.08 | 10.95 | 22.83 | 14.93 |
Other Long-Term Liabilities | 4.6 | 4.82 | 5.52 | 8.32 | 11.53 | 14.4 |
Total Long-Term Liabilities | 89.3 | 94.89 | 58.03 | 77.01 | 96.43 | 65.09 |
Total Liabilities | 305.9 | 301.92 | 320.54 | 280.01 | 297.46 | 276.3 |
Common Stock | 9.7 | 9.71 | 9.71 | 9.71 | 9.71 | 4.85 |
Additional Paid-in Capital | 336.2 | 336.2 | 336.2 | 336.2 | 336.76 | 202.39 |
Accumulated Other Comprehensive Income | 47.2 | 23.52 | 48.5 | 30.65 | 42.48 | 16.99 |
Retained Earnings | -218.2 | -201.79 | -198.05 | 98.53 | 73.56 | 71.51 |
Shareholders' Equity | 174.9 | 167.64 | 196.37 | 475.1 | 462.5 | 295.74 |
Total Liabilities & Equity | 480.8 | 469.56 | 516.91 | 755.11 | 759.96 | 572.03 |
Total Debt | 227.3 | 223.76 | 195.06 | 166.17 | 189.97 | 155.44 |
Net Cash (Debt) | -207.7 | -204.13 | -172.41 | -128.89 | -93.06 | -117.26 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -12.73 | -5.26 | -4.44 | -3.32 | -3.27 | -4.31 |
Book Value | 174.9 | 167.64 | 196.37 | 475.1 | 462.5 | 295.74 |
Book Value Per Share | 10.72 | 4.32 | 5.06 | 12.23 | 16.24 | 10.87 |
Tangible Book Value | 86.1 | 82.75 | 96.96 | 96.05 | 149.15 | 54.16 |
Tangible Book Value Per Share | 5.28 | 2.13 | 2.50 | 2.47 | 5.24 | 1.99 |